The aim of this analysis is to explain the role of precise medication in cow dairy allergy detection, treatment and monitoring. In the area of food allergy, the invention of omics has contributed to a greater understanding of the allergic characteristics of the cow’s milk proteins and important developments in the knowledge of pathogenesis and cow’s milk allergy mechanisms. Omic technology allows the doctor to help distinguish subtypes of cow’s milk allergy and to predict the persistence of cow’s milk allergy (CMA) across time.Precision medicine expands the function of the oral food problem, determining the threshold doses of individuals and establishing tolerance of baked milk products. Apart from relief of symptoms, nutritional interventions for the ability to lead resistance are still under investigation. For patients with severe and chronic IgE-mediated CMA, orally Immunotherapy provides a treatment choice. Cow’s milk oral immunotherapy protection and efficacy can be predicted by individual baseline-immune profiles. New technological evidence may be turned into therapies for personalised procedures, in conjunction with case history.
Identifying new biomarkers will enhance diagnosis precision and even predict patients’ reaction to therapies. Patient data integration is becoming more and more relevant as omics technology is used more and more in the healthcare environment.
